Researchers are gearing up to collect stool and blood samples from willing participants to study the effects that the bacteria comprising the gut microbiome could have on COVID-19 vaccine efficacy. This would involve a weeks-worth of pills with dried bacteria to take along with vaccination to boost the immune system and enhance vaccine efficacy. The therapy differs from a probiotic in that it involves novel bacteria from the gut microbiome necessitating FDA guidance and approval, the CEO explained. Any patients who go on to develop COVID-19 would become eligible for an additional part of the study involving sequencing of variants. Depending on the results of the study, messaging could extend as far as advising against taking antibiotics prior to vaccination, the CEO confirmed.

Source: Fox News March 30, 2021 18:00 UTC